Physician

George J Ko, MD

According to 2025 Medicare claims, George Ko, MD (NPI: 1205890514) practices ophthalmology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is RETINA INSTITUTE, PLLC (NPI: 1528303849; TIN: 461427591) and primary practice location at 98055-6238. Ko is affiliated with the MultiCare Connected Care, LLC (ACO ID: A3631), participating under the MSSP model.

Ko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 703 traditional Medicare patients, billed 16,361 HCPCS/CPT codes, and received $1,713,840 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 418 prescription claims across 141 beneficiaries totaling $31,903 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 8 records totaling $172. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $74,005 to $31,903. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2015 Medicare payment: $2,260,397 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,749,773 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,025,469 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,440,427 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,592,146 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,424,584 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,023,348 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,173,349 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,784,019 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,713,840 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,13416,258$2,260,397
20161,04018,380$2,749,773
20171,12916,191$2,025,469
20181,04716,165$2,440,427
20191,04515,718$2,592,146
202090413,054$2,424,584
202186311,175$2,023,348
20221,01511,663$2,173,349
202386310,709$1,784,019
202470316,361$1,713,840

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$37K$74K2015 Drug cost: $74,005 (USD; Tot_Drug_Cst)2016 Drug cost: $53,764 (USD; Tot_Drug_Cst)2017 Drug cost: $49,145 (USD; Tot_Drug_Cst)2018 Drug cost: $48,022 (USD; Tot_Drug_Cst)2019 Drug cost: $49,348 (USD; Tot_Drug_Cst)2020 Drug cost: $52,588 (USD; Tot_Drug_Cst)2021 Drug cost: $34,144 (USD; Tot_Drug_Cst)2022 Drug cost: $41,856 (USD; Tot_Drug_Cst)2023 Drug cost: $45,562 (USD; Tot_Drug_Cst)2024 Drug cost: $31,903 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015208722$74,005
2016211677$53,764
2017222764$49,145
2018232744$48,022
2019233722$49,348
2020196686$52,588
2021190498$34,144
2022212629$41,856
2023149469$45,562
2024141418$31,903

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2691,058$105
92014Established patient complete exam of visual system542889$97
92012Established patient problem focused exam of visual system219490$71
92134Imaging of retina397970$33
92250Photography of the retina566824$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium18867$6,349
Prednisolone AcetatePrednisolone Acetate933,351$5,248
Bromfenac SodiumBromfenac Sodium16827$2,886
EplerenoneEplerenone11570$1,325
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat553,065$977

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$172ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for George J. Ko, MD?

Tedicare shows public-source Medicare data for George J. Ko, MD (NPI 1205890514), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George J. Ko, MD have ACO affiliation data?

George J. Ko, MD is shown with ACO affiliation data for MultiCare Connected Care, LLC (MSSP, ACO ID A3631).

What billing organization is linked to George J. Ko, MD?

George J. Ko, MD is linked to RETINA INSTITUTE, PLLC (billing NPI 1528303849) in the available physician profile data.

Does George J. Ko, MD have Open Payments data?

George J. Ko, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.